Colivelin (0.5mg)
$70.00
- Sequence (single letter)
- SALLRSIPAPAGASRLLLLTGEIDLP
- Sequence (three letter)
- H-Ser-Ala-Leu-Leu-Arg-Ser-Ile-Pro-Ala-Pro-Ala-Gly-Ala-Ser-Arg-Leu-Leu-Leu-Leu-Thr-Gly-Glu-Ile-Asp-Leu-Pro-OH
- Molecular Formula
- C119H206N32O35
- Molecular Weight
- 2645.3
- CAS Number
- 867021-83-8
- Lyophilized peptides should be reconstituted using proper aseptic laboratory technique.
- Reconstitution must be performed using Canlab-supplied Bacteriostatic Water and handled in accordance with generally accepted research practices.
- Warranty related to reconstitution, sterility or material integrity applies only when Canlab Bacteriostatic Water is used.
- Use of third-party diluents or deviation from the provided handling guidance voids any applicable warranty.
For full handling instructions and limitations, see the Peptide Reconstitution section in our Product Warranty Policy Page →
Description
This novel peptide, colivelin, was engineered to enhance the neuroprotective capabilities of humanin (HN). It combines Activity-Dependent Neurotrophic Factor (ADNF) with AGA-(C8R) HNG17, a robust HN derivative. Colivelin has demonstrated remarkable potential by entirely halting cell death triggered by overexpressed genes causing Familial Alzheimer’s disease (FAD) and beta-amyloid (1-43). When administered intraperitoneally, colivelin effectively mitigates memory impairment, presenting itself as a promising candidate for the treatment of Alzheimer’s disease.
Additional Information
Benefits
Please review the complete product description and available supporting documentation for product-specific research information.
Mechanism of Action
Refer to the product description, certificate of analysis and applicable published research for product-specific information. No medical or therapeutic claims are made.





